Surmodics, Inc. (SRDX)
NASDAQ: SRDX · Real-Time Price · USD
34.85
+0.47 (1.37%)
Feb 21, 2025, 4:00 PM EST - Market closed
Surmodics Market Cap
Surmodics has a market cap or net worth of $498.22 million as of February 21, 2025. Its market cap has increased by 13.80% in one year.
Market Cap
498.22M
Enterprise Value
501.10M
1-Year Change
13.80%
Ranking
Category
Stock Price
$34.85
Market Cap Chart
Since December 1, 1998, Surmodics's market cap has increased from $67.50M to $498.22M, an increase of 638.10%. That is a compound annual growth rate of 7.92%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Feb 20, 2025 | 491.50M | -13.36% |
Dec 31, 2024 | 567.30M | 10.24% |
Dec 29, 2023 | 514.60M | 7.43% |
Dec 30, 2022 | 479.00M | -28.45% |
Dec 31, 2021 | 669.50M | 12.48% |
Dec 31, 2020 | 595.20M | 6.04% |
Dec 31, 2019 | 561.30M | -11.36% |
Dec 31, 2018 | 633.20M | 72.63% |
Dec 29, 2017 | 366.80M | 9.33% |
Dec 30, 2016 | 335.50M | 27.86% |
Dec 31, 2015 | 262.40M | -7.67% |
Dec 31, 2014 | 284.20M | -15.16% |
Dec 31, 2013 | 335.00M | 2.20% |
Dec 31, 2012 | 327.80M | 27.55% |
Dec 30, 2011 | 257.00M | 23.97% |
Dec 31, 2010 | 207.30M | -47.64% |
Dec 31, 2009 | 395.90M | -11.31% |
Dec 31, 2008 | 446.40M | -54.99% |
Dec 31, 2007 | 991.70M | 73.25% |
Dec 29, 2006 | 572.40M | -16.56% |
Dec 30, 2005 | 686.00M | 19.85% |
Dec 31, 2004 | 572.40M | 38.03% |
Dec 31, 2003 | 414.70M | -16.41% |
Dec 31, 2002 | 496.10M | -18.92% |
Dec 31, 2001 | 611.90M | 0.02% |
View and export this data all the way back to 1998.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 784.71B |
UnitedHealth Group | 429.24B |
Novo Nordisk | 391.83B |
Johnson & Johnson | 390.76B |
AbbVie | 356.74B |
Abbott Laboratories | 234.01B |
AstraZeneca | 229.50B |
Merck & Co. | 226.40B |